Literature DB >> 2974264

Mesocortical dopaminergic function and human cognition.

D R Weinberger1, K F Berman, T N Chase.   

Abstract

In summary, we have reviewed rCBF data in humans that suggest that mesoprefrontal dopaminergic activity is involved in human cognition. In patients with Parkinson's disease and possibly in patients with schizophrenia, prefrontal physiological activation during a cognitive task that appears to depend on prefrontal neural systems correlates positively with cognitive performance on the task and with clinical signs of dopaminergic function. It may be possible in the future to examine prefrontal dopamine metabolism directly during prefrontal cognition using positron emission tomography and tracers such as F-18 DOPA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974264     DOI: 10.1111/j.1749-6632.1988.tb42117.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

1.  Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.

Authors:  G D Honey; E T Bullmore; W Soni; M Varatheesan; S C Williams; T Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia.

Authors:  Diana P Prata; Andrea Mechelli; Cynthia H Y Fu; Marco Picchioni; Timothea Toulopoulou; Elvira Bramon; Muriel Walshe; Robin M Murray; David A Collier; Philip McGuire
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

Review 3.  α2-Adrenoceptors are targets for antipsychotic drugs.

Authors:  Jan Brosda; Florian Jantschak; Heinz H Pertz
Journal:  Psychopharmacology (Berl)       Date:  2014-02-02       Impact factor: 4.530

4.  Dopamine modulates egalitarian behavior in humans.

Authors:  Ignacio Sáez; Lusha Zhu; Eric Set; Andrew Kayser; Ming Hsu
Journal:  Curr Biol       Date:  2015-03-19       Impact factor: 10.834

Review 5.  Prefrontal cortical dopamine from an evolutionary perspective.

Authors:  Young-A Lee; Yukiori Goto
Journal:  Neurosci Bull       Date:  2015-01-23       Impact factor: 5.203

Review 6.  Dopamine hypothesis of schizophrenia: making sense of it all.

Authors:  Mitsuru Toda; Anissa Abi-Dargham
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

Review 7.  Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.

Authors:  Amy F T Arnsten; Ragy R Girgis; David L Gray; Richard B Mailman
Journal:  Biol Psychiatry       Date:  2016-01-18       Impact factor: 13.382

8.  Anhedonia as a phenotype for the Val158Met COMT polymorphism in relatives of patients with schizophrenia.

Authors:  Anna R Docherty; Scott R Sponheim
Journal:  J Abnorm Psychol       Date:  2008-11

Review 9.  Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review.

Authors:  Birgit Guse; Peter Falkai; Thomas Wobrock
Journal:  J Neural Transm (Vienna)       Date:  2009-10-27       Impact factor: 3.575

10.  Dynamic Connectivity between Brain Networks Supports Working Memory: Relationships to Dopamine Release and Schizophrenia.

Authors:  Clifford M Cassidy; Jared X Van Snellenberg; Caridad Benavides; Mark Slifstein; Zhishun Wang; Holly Moore; Anissa Abi-Dargham; Guillermo Horga
Journal:  J Neurosci       Date:  2016-04-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.